[Clinical aspects of neuroborreliosis].
Pfister
Hans-Walter
HW
Neurologische Klinik und Poliklinik, Klinikum München-Grosshadern, LMU München. Hans-Walter.Pfister@med.uni-muenchen.de
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D002443:Ceftriaxone / Q000627:therapeutic use*; D054382:Chemokine CXCL13 / Q000134:cerebrospinal fluid; D002908:Chronic Disease; D015787:Erythema Chronicum Migrans / Q000175:diagnosis; D006801:Humans; D020852:Lyme Neuroborreliosis / Q000175:diagnosis* / Q000188:drug therapy* / Q000276:immunology; D008213:Lymphocyte Activation / Q000276:immunology; D009460:Neurologic Examination
D000900:Anti-Bacterial Agents; C110663:CXCL13 protein, human; D054382:Chemokine CXCL13; D002443:Ceftriaxone